Azenta/AZTA

$50.65

0.31%
-
1D1W1MYTD1YMAX

About Azenta

Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company’s segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.

Ticker

AZTA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Stephen Schwartz

Employees

3,500

Headquarters

Burlington, United States

Azenta Metrics

BasicAdvanced
$2.82B
Market cap
-
P/E ratio
-$0.32
EPS
1.52
Beta
-
Dividend rate
$2.82B
1.52318
$69.16
$36.01
443.84K
5.869
5.329
58.356
-0.57%
-0.65%
-0.62%
4.392
1.151
2.081
86.826
7.88%
13.32%
19.62%

What the Analysts think about Azenta

Analyst Ratings

Majority rating from 7 analysts.
Hold

Price Targets

Average projection from 5 analysts.
37.41% upside
High $79.00
Low $60.00
$50.65
Current price
$69.60
Average price target

Azenta Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-10.17% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$154.3M
-10.45%
Net income
$-15.7M
-575.76%
Profit margin
-10.17%
-632.46%

Azenta Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 159.88%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.06
$0.13
$0.13
$0.02
-
Expected
-$0.02
-$0.02
$0.02
-$0.03
$0.02
Surprise
172.73%
-714.16%
628.99%
-159.88%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Azenta stock?

Azenta (AZTA) has a market cap of $2.82B as of April 20, 2024.

What is the P/E ratio for Azenta stock?

The price to earnings (P/E) ratio for Azenta (AZTA) stock is 0 as of April 20, 2024.

Does Azenta stock pay dividends?

No, Azenta (AZTA) stock does not pay dividends to its shareholders as of April 20, 2024.

When is the next Azenta dividend payment date?

Azenta (AZTA) stock does not pay dividends to its shareholders.

What is the beta indicator for Azenta?

Azenta (AZTA) has a beta rating of 1.52. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Azenta stock price target?

The target price for Azenta (AZTA) stock is $69.6, which is 37.41% above the current price of $50.65. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Azenta stock

Buy or sell Azenta stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing